Jennifer Ziolkowski's Insider Trades & SAST Disclosures
Jennifer Ziolkowski's most recent trade in Vigil Neuroscience Inc was a trade of 156,000 Stock Option Award (Right to Buy) done . Disclosure was reported to the exchange on March 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jennifer Ziolkowski.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vigil Neuroscience Inc | Jennifer Ziolkowski | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 156,000 | 156,000 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Jennifer Ziolkowski | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 May 2024 | 135,000 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Jennifer Ziolkowski | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 135,000 | 135,000 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Jennifer Ziolkowski | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 May 2024 | 110,000 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Jennifer Ziolkowski | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 110,000 | 110,000 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Jennifer Ziolkowski | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 156,000 | 156,000 | - | - | Stock Option Grant (Right to Buy) | |
| Vigil Neuroscience Inc | Jennifer Ziolkowski | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 135,000 | 135,000 | - | - | Stock Option Grant (Right to Buy) | |
| Vigil Neuroscience Inc | Jennifer Ziolkowski | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.77 per share. | 03 May 2022 | 4,000 | 4,000 | - | 3.8 | 15,098 | Common Stock |
| Vigil Neuroscience Inc | Jennifer Ziolkowski | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 110,000 | 110,000 | - | - | Stock Option Grant (Right to Buy) | |
| Solid Biosciences Inc | Jennifer Ziolkowski | CFO, Treasurer & Asst. Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2021 | 11,500 | 0 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Jennifer Ziolkowski | CFO, Treasurer & Asst. Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2021 | 11,500 | 339,109 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Jennifer Ziolkowski | CFO, Treasurer & Asst. Secy | Sale of securities on an exchange or to another person at price $ 6.14 per share. | 27 Jan 2021 | 3,473 | 335,636 (0%) | 0% | 6.1 | 21,327 | Common Stock |
| Solid Biosciences Inc | Jennifer Ziolkowski | CFO, Treasurer & Asst. Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2020 | 11,500 | 331,200 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Jennifer Ziolkowski | CFO, Treasurer & Asst. Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2020 | 11,500 | 11,500 | - | - | Restricted Stock UNits | |
| Solid Biosciences Inc | Jennifer Ziolkowski | CFO, Treasurer & Asst. Secy | Sale of securities on an exchange or to another person at price $ 2.42 per share. | 27 Jul 2020 | 3,591 | 327,609 (0%) | 0% | 2.4 | 8,687 | Common Stock |
| Solid Biosciences Inc | Jennifer Ziolkowski | CFO, Treasurer & Asst. Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 75,000 | 319,700 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges